Dr. Dr S. Torfay-Roman

Ayman Koteish is a Transplant Surgeon practicing medicine in Orlando, Florida. Dr. Koteish is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Hepatitis, Nonalcoholic Steatohepatitis (NASH), Visceromegaly, Enlarged Liver, and Liver Transplant. Dr. Koteish is currently accepting new patients.

Dr. Juan Carlos Varela is a board-certified and fellowship-trained physician specializing in hematology and oncology with the Bone Marrow Transplant and Cellular Therapy program at the Orlando Health Cancer Institute. He previously served as medical director of a Blood and Marrow Transplant/Cellular Therapy program in Orlando and most recently was medical director for Outpatient Services and led the Acute Leukemia and Bone Marrow Transplant Program in the Division of Hematological Malignancies in Boston. His services include: Bone marrow transplants (autologous, allogeneic, cord blood and haploidentical) Bispecific antibodies CAR-T cell therapy Acute leukemia myelodysplastic syndrome treatment Cellular therapy lab (on-site collection facility and cell manipulation) Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma, graft versus host disease and lung transplant rejection Clinical trials Dr. Varela takes his patients' specific goals and needs into account in order to treat each patient as an individual, rather than taking a blanket approach to treating the disease. Dr. Varela's Training Dr. Varela earned his medical degree and doctorate from the Medical University of South Carolina in Charleston. He completed an internal medicine residency and hematology fellowship at The Johns Hopkins Hospital in Baltimore. About Dr. Varela Dr. Varela is certified in hematology and internal medicine with the American Board of Internal Medicine. He is a member of the American Society for Transplantation and Cellular Therapy and American Society of Hematology. Dr. Varela is a physician scientist and has been the principal investigator in dozens of clinical trials for cellular therapy, hematologic malignancies and bone marrow transplants. He has successfully translated novel immunotherapeutic approaches from the bench to the bedside and has been the leader in multiple first-in-human studies of novel T-cell therapies in hematologic malignancies. His research has been published extensively in peer-reviewed publications on topics including hematopoietic stem cell transplantation, acute myelogenous leukemia and adoptive T cell immunotherapy. Outside of work, Dr. Varela enjoys music, sports and spending time with his family. He is fluent in English and Spanish. Dr. Varela is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Acute Myeloblastic Leukemia with Maturation, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Varela is board certified in American Board Of Internal Medicine - Hematology and American Board Of Internal Medicine - Internal Medicine. Dr. Varela is currently accepting new patients.

Dr. Yasser Khaled is the medical director of the bone marrow transplant and cellular therapy program at the Orlando Health Cancer Institute. He is board-certified in hematology and specializes in cellular therapy and blood and bone marrow transplantation. His areas of expertise include: Bone marrow transplants (autologous, allogeneic, cord blood and haploidentical) Bispecific antibodies CAR-T cell therapy Acute leukemia/myelodysplastic syndrome treatment Cellular therapy lab (on-site collection facility and cell manipulation) Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma, graft versus host disease and lung transplant rejection Clinical trials Dr. Khaled's Training Dr. Khaled received his medical training at Cairo University School of Medicine in Egypt. He completed a residency in internal medicine at Woodhull Medical Center in New York. Dr. Khaled also completed fellowships in medical oncology at Virginia Commonwealth University in Richmond, in hematology at New York Medical College in Valhalla and in blood and bone marrow transplantation at the University of Texas / MD Anderson Cancer Center in Houston. About Dr. Khaled Dr. Khaled is board-certified in hematology by the American Board of Internal Medicine. Before joining Orlando Health, Dr. Khaled served as medical director of the Blood and Marrow Transplant Center at Methodist Le Bonheur Health Care in Memphis. In less than four years, he led the program to a top 10 percent ranking in survival outcomes, according to the National Marrow Donor Program, an independent agency that reviews the outcomes of bone marrow transplant centers in the United States. He also brought the first cellular immune therapy (CAR-T cell) for the treatment of lymphoma and acute leukemia to Memphis and the Mid-South, an achievement that earned him an award as a Memphis Health Care Hero in 2019. Dr. Khaled has an established research career in stem cell transplantation as principal investigator and co-investigator for multiple industry- and NIH-funded protocols. He also has published extensively in the field of stem cell transplantation with dozens of articles and abstracts. Dr. Khaled is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Graft Versus Host Disease (GvHD), Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Khaled is board certified in American Board Of Internal Medicine - Hematology. Dr. Khaled is currently accepting new patients.